{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T21:42:01Z","timestamp":1777153321167,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.rdc.2014.01.008","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T05:45:13Z","timestamp":1392788713000},"page":"329-341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of Acute Gout"],"prefix":"10.1016","volume":"40","author":[{"given":"Naomi","family":"Schlesinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2014.01.008_bib1","unstructured":"Weede RP. Poison in the pot: the legacy of lead. Carbondale and Edwardsville (IL): Southern Illinois University Press; 1984. p. 83. In: Porter R, Rousseau GS, editors. Gout the patrician malady. Yale University Press; 1998."},{"key":"10.1016\/j.rdc.2014.01.008_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","article-title":"Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of nonsteroidal anti-inflammatory drugs","volume":"24","author":"Bellamy","year":"1987","journal-title":"Br J Clin Pharmacol"},{"issue":"21","key":"10.1016\/j.rdc.2014.01.008_bib3","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.rdc.2014.01.008_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/art.1780150607","article-title":"Effect of exercise on urate crystal-induced inflammation in canine joints","volume":"15","author":"Agudelo","year":"1972","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2A","key":"10.1016\/j.rdc.2014.01.008_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-9343(97)89546-0","article-title":"Crystal induced arthritis: an overview","volume":"100","author":"Schumacher","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.rdc.2014.01.008_bib6","first-page":"331","article-title":"Local ice therapy during bouts of acute gouty arthritis","volume":"29","author":"Schlesinger","year":"2002","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/art.1780170510","article-title":"Effects of cold and heat on urate-induced synovitis in dog","volume":"17","author":"Dorwart","year":"1974","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2014.01.008_bib9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/acr.21773","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and anti-inflammatory prophylaxis of acute gouty arthritis","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.rdc.2014.01.008_bib10","first-page":"2050","article-title":"A\u00a0survey of current evaluation and treatment of gout","volume":"33","author":"Schlesinger","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib11","first-page":"1566","article-title":"Treatment of acute gout in hospitalized patients","volume":"34","author":"Petersel","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2014.01.008_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1445-5994.2010.02165.x","article-title":"Acute gout management during hospitalisation: a need for a protocol","volume":"41","author":"Gnanenthiran","year":"2011","journal-title":"Intern Med J"},{"key":"10.1016\/j.rdc.2014.01.008_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1756-185X.2009.01431.x","article-title":"A\u00a0survey on the management of gout in Malaysia","volume":"12","author":"Yeap","year":"2009","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.rdc.2014.01.008_bib14","first-page":"1841","article-title":"A\u00a0survey of current prescribing practices of anti-inflammatory and urate lowering drugs in gouty arthritis in the Province of Ontario","volume":"15","author":"Bellamy","year":"1988","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib15","doi-asserted-by":"crossref","first-page":"537","DOI":"10.5694\/j.1326-5377.1989.tb128510.x","article-title":"Survey of current prescribing practices of anti-inflammatory and urate lowering drugs in gouty arthritis in New South Wales and Queensland","volume":"151","author":"Bellamy","year":"1989","journal-title":"Med J Aust"},{"issue":"908","key":"10.1016\/j.rdc.2014.01.008_bib16","first-page":"115","article-title":"A\u00a0survey of current prescribing practices of anti-inflammatory and urate-lowering drugs in gouty arthritis","volume":"104","author":"Stuart","year":"1991","journal-title":"N\u00a0Z Med J"},{"key":"10.1016\/j.rdc.2014.01.008_bib17","first-page":"255","article-title":"Diversity of opinions on the management of gout in France. A survey of 750 rheumatologists","volume":"63","author":"Rozenberg","year":"1996","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.rdc.2014.01.008_bib18","first-page":"2041","article-title":"The management of gout at an academic healthcare center in Beijing: a physician survey","volume":"33","author":"Fang","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2014.01.008_bib19","first-page":"374","article-title":"A\u00a0survey of current prescribing practices in gouty arthritis and symptomatic hyperuricemia in San Paulo, Brazil","volume":"21","author":"Ferraz","year":"1994","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2014.01.008_bib20","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.reuma.2012.05.008","article-title":"A\u00a0survey on the current evaluation and treatment of gout in Buenos Aires, Argentina","volume":"8","author":"Fara","year":"2012","journal-title":"Reumatol Clin"},{"issue":"9","key":"10.1016\/j.rdc.2014.01.008_bib21","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1093\/rheumatology\/ket158","article-title":"Primary care providers' knowledge, beliefs and treatment practices for gout: results of a physician questionnaire","volume":"52","author":"Harrold","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2014.01.008_bib22","series-title":"Basic and Clinical Pharmacology","first-page":"578","article-title":"Nonsteroidal antiinflammatory drugs; disease-modifying antirheumatic drugs; nonopioid analgesics; drugs used in gout","author":"Katzung","year":"1998"},{"key":"10.1016\/j.rdc.2014.01.008_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.rdc.2014.01.008_bib24","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/j.1875-9114.1991.tb02629.x","article-title":"Colchicine: a state-of-the-art review","volume":"11","author":"Levy","year":"1991","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1016\/j.rdc.2014.01.008_bib25","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.2165\/11205470-000000000-00000","article-title":"Oral colchicine (Colcrys\u00ae) in the treatment and prophylaxis of gout","volume":"70","author":"Yang","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/j.rdc.2014.01.008_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","article-title":"High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study","volume":"63","author":"Terkeltaub","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? Results of the first controlled study in gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.rdc.2014.01.008_bib28","unstructured":"Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cder\/drugsatfda\/index.cfm?fuseaction=Search.DrugDetails#.UvP36k3PMA8.email. Accessed February 6, 2014."},{"issue":"4","key":"10.1016\/j.rdc.2014.01.008_bib29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2008.08.001","article-title":"Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention","volume":"39","author":"Vonkeman","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib30","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac (Lodine) compared with naproxen in patients with acute gout","volume":"12","author":"Macagno","year":"1991","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.rdc.2014.01.008_bib31","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2014.01.008_bib32","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3899\/jrheum.110916","article-title":"Efficacy and tolerability of celecoxib in the treatment of acute gouty arthritis: a randomized controlled trial","volume":"39","author":"Schumacher","year":"2012","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/phrs.2002.0969","article-title":"Molecular mechanisms of immunomodulatory activity of glucocorticoids","volume":"45","author":"Riccardi","year":"2002","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.rdc.2014.01.008_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature","volume":"19","author":"Groff","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib35","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.rdc.2014.01.008_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0140-6736(08)60799-0","article-title":"Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomized equivalence trial","volume":"371","author":"Janssens","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.rdc.2014.01.008_bib37","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib38","first-page":"1325","article-title":"Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of gouty arthritis","volume":"21","author":"Seigel","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib39","first-page":"2285","article-title":"Treatment of acute attacks of gout with small doses of intraarticular triamcinolone acetonide","volume":"26","author":"Fernandez","year":"1999","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.rdc.2014.01.008_bib40","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1002\/art.10526","article-title":"Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis","volume":"46","author":"Getting","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib41","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.4049\/jimmunol.162.12.7446","article-title":"POMC gene derived peptides activate MC3R on murine macrophages, suppress cytokine release and inhibit neutrophil migration in acute experimental inflammation","volume":"162","author":"Getting","year":"1999","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.rdc.2014.01.008_bib42","first-page":"696","article-title":"ACTH revisited: effective treatment for acute crystal induced synovitis in patients with multiple medical problems","volume":"21","author":"Ritter","year":"1994","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2014.01.008_bib43","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib44","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.4049\/jimmunol.138.10.3213","article-title":"Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1","volume":"138","author":"Di Giovine","year":"1987","journal-title":"J\u00a0Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.rdc.2014.01.008_bib45","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/ar1908","article-title":"The inflammatory process of gout and its treatment","volume":"8","author":"Cronstein","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2014.01.008_bib46","unstructured":"Available at: http:\/\/webcache.googleusercontent.com\/search?q=cache:2mNlWDW2pVMJ:www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Assessment_Report_-_Variation\/human\/001109\/WC500140963.pdf+Canakinumab+is+approved+for+use+in+acute+gout+by+the+EMEA&cd=2&hl=en&ct=clnk&gl=us. Accessed February 6, 2014."},{"issue":"2","key":"10.1016\/j.rdc.2014.01.008_bib47","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2143","article-title":"A\u00a0pilot study of IL-1 inhibition by anakinra in acute gout","volume":"9","author":"So","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"Suppl 9","key":"10.1016\/j.rdc.2014.01.008_bib48","first-page":"S163","article-title":"The safety and efficacy of anakinra in the treatment of acute gout in hospitalized patients","volume":"60","author":"Cho","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2014.01.008_bib49","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","article-title":"Canakinumab for acute gouty arthritis in\u00a0patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions","volume":"71","author":"Schlesinger","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2014.01.008_bib50","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/ar4159","article-title":"Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2014.01.008_bib51","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780080502","article-title":"Treatment of primary gout: the present status","volume":"8","author":"Gutman","year":"1965","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1400009X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1400009X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:13:18Z","timestamp":1760181198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X1400009X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0889857X1400009X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2014.01.008","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Acute Gout","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2014.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}